OBJECTIVE: Past studies have shown that measures of attentional control and semantic memory are sensitive markers of Alzheimer's disease (AD). The effects of established biomarkers of AD (cerebrospinal fluid tau and amyloid-beta42, positron emission tomography Pittsburgh compound-B, and apolipoprotein E [APOE] genotype) on concurrent cognitive performance in cognitively normal individuals have been mixed. The present study examined the utility of combining attentional control with semantic retrieval as a sensitive correlate of AD biomarkers and used mediation analyses to examine possible mechanisms by which the biomarkers influence cognition. METHOD: Three hundred sixty-three participants completed a category verification task (CVT), and 113 of them concurrently underwent biomarker assessments. On each trial, participants viewed a category (e.g., "unit of time") and verified whether a subsequent target item was an exemplar of the category ("hour") or not ("clock"). Importantly, the nonmembers of the category were associatively related to the category (e.g., "clock" is not "a unit of time," but is highly related), and demanded attentional control to reject. RESULTS: Accuracy to the foil items was the strongest discriminator between healthy aging and very mild symptomatic AD. Cerebrospinal fluid biomarkers had independent yet synergistic influence on CVT performance in cognitively healthy older adults. Furthermore, the influence of the biomarkers and APOE genotype was mediated primarily through increased levels of PIB. CONCLUSION: The combined influence of attentional control with semantic retrieval is a marker of symptomatic AD and a sensitive correlate of established biomarkers for AD risk in cognitively healthy participants. The biomarkers influenced cognition primarily through increased levels of amyloid in the brain. (c) 2015 APA, all rights reserved).
OBJECTIVE: Past studies have shown that measures of attentional control and semantic memory are sensitive markers of Alzheimer's disease (AD). The effects of established biomarkers of AD (cerebrospinal fluid tau and amyloid-beta42, positron emission tomography Pittsburgh compound-B, and apolipoprotein E [APOE] genotype) on concurrent cognitive performance in cognitively normal individuals have been mixed. The present study examined the utility of combining attentional control with semantic retrieval as a sensitive correlate of AD biomarkers and used mediation analyses to examine possible mechanisms by which the biomarkers influence cognition. METHOD: Three hundred sixty-three participants completed a category verification task (CVT), and 113 of them concurrently underwent biomarker assessments. On each trial, participants viewed a category (e.g., "unit of time") and verified whether a subsequent target item was an exemplar of the category ("hour") or not ("clock"). Importantly, the nonmembers of the category were associatively related to the category (e.g., "clock" is not "a unit of time," but is highly related), and demanded attentional control to reject. RESULTS: Accuracy to the foil items was the strongest discriminator between healthy aging and very mild symptomatic AD. Cerebrospinal fluid biomarkers had independent yet synergistic influence on CVT performance in cognitively healthy older adults. Furthermore, the influence of the biomarkers and APOE genotype was mediated primarily through increased levels of PIB. CONCLUSION: The combined influence of attentional control with semantic retrieval is a marker of symptomatic AD and a sensitive correlate of established biomarkers for AD risk in cognitively healthy participants. The biomarkers influenced cognition primarily through increased levels of amyloid in the brain. (c) 2015 APA, all rights reserved).
Authors: K M Rodrigue; K M Kennedy; M D Devous; J R Rieck; A C Hebrank; R Diaz-Arrastia; D Mathews; D C Park Journal: Neurology Date: 2012-02-01 Impact factor: 9.910
Authors: Niklas Mattsson; Ulf Andreasson; Staffan Persson; Hiroyuki Arai; Sat Dev Batish; Sergio Bernardini; Luisella Bocchio-Chiavetto; Marinus A Blankenstein; Maria C Carrillo; Sonia Chalbot; Els Coart; Davide Chiasserini; Neal Cutler; Gunilla Dahlfors; Stefan Duller; Anne M Fagan; Orestes Forlenza; Giovanni B Frisoni; Douglas Galasko; Daniela Galimberti; Harald Hampel; Aase Handberg; Michael T Heneka; Adrianna Z Herskovits; Sanna-Kaisa Herukka; David M Holtzman; Christian Humpel; Bradley T Hyman; Khalid Iqbal; Mathias Jucker; Stephan A Kaeser; Elmar Kaiser; Elisabeth Kapaki; Daniel Kidd; Peter Klivenyi; Cindy S Knudsen; Markus P Kummer; James Lui; Albert Lladó; Piotr Lewczuk; Qiao-Xin Li; Ralph Martins; Colin Masters; John McAuliffe; Marc Mercken; Abhay Moghekar; José Luis Molinuevo; Thomas J Montine; William Nowatzke; Richard O'Brien; Markus Otto; George P Paraskevas; Lucilla Parnetti; Ronald C Petersen; David Prvulovic; Herman P M de Reus; Robert A Rissman; Elio Scarpini; Alessandro Stefani; Hilkka Soininen; Johannes Schröder; Leslie M Shaw; Anders Skinningsrud; Brith Skrogstad; Annette Spreer; Leda Talib; Charlotte Teunissen; John Q Trojanowski; Hayrettin Tumani; Robert M Umek; Bianca Van Broeck; Hugo Vanderstichele; Laszlo Vecsei; Marcel M Verbeek; Manfred Windisch; Jing Zhang; Henrik Zetterberg; Kaj Blennow Journal: Alzheimers Dement Date: 2011-07 Impact factor: 21.566
Authors: Kerryn E Pike; Kathryn A Ellis; Victor L Villemagne; Norm Good; Gael Chételat; David Ames; Cassandra Szoeke; Simon M Laws; Giuseppe Verdile; Ralph N Martins; Colin L Masters; Christopher C Rowe Journal: Neuropsychologia Date: 2011-04-16 Impact factor: 3.139
Authors: Prashanthi Vemuri; Stephen D Weigand; Scott A Przybelski; David S Knopman; Glenn E Smith; John Q Trojanowski; Leslie M Shaw; Charlie S Decarli; Owen Carmichael; Matt A Bernstein; Paul S Aisen; Michael Weiner; Ronald C Petersen; Clifford R Jack Journal: Brain Date: 2011-04-07 Impact factor: 13.501
Authors: Andrew J Aschenbrenner; David A Balota; Anne M Fagan; Janet M Duchek; Tammie L S Benzinger; John C Morris Journal: J Int Neuropsychol Soc Date: 2015-09 Impact factor: 2.892
Authors: Guoqiao Wang; Dean Coble; Eric M McDade; Jason Hassenstab; Anne M Fagan; Tammie L S Benzinger; Randall J Bateman; John C Morris; Chengjie Xiong Journal: Alzheimers Dement Date: 2019-02-15 Impact factor: 21.566
Authors: Shruti Mishra; Brian A Gordon; Yi Su; Jon Christensen; Karl Friedrichsen; Kelley Jackson; Russ Hornbeck; David A Balota; Nigel J Cairns; John C Morris; Beau M Ances; Tammie L S Benzinger Journal: Neuroimage Date: 2017-07-26 Impact factor: 6.556
Authors: Brian A Gordon; Jeffrey M Zacks; Tyler Blazey; Tammie L S Benzinger; John C Morris; Anne M Fagan; David M Holtzman; David A Balota Journal: Neurobiol Aging Date: 2015-01-29 Impact factor: 4.673
Authors: Peter R Millar; David A Balota; Geoffrey B Maddox; Janet M Duchek; Andrew J Aschenbrenner; Anne M Fagan; Tammie L S Benzinger; John C Morris Journal: Neuropsychology Date: 2017-02-16 Impact factor: 3.295
Authors: Andrew J Aschenbrenner; Brian A Gordon; Anne M Fagan; Suzanne E Schindler; David A Balota; John C Morris; Jason J Hassenstab Journal: J Alzheimers Dis Date: 2020 Impact factor: 4.472